Clinical Trial Update: 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults [Phase 1]

View source ↗

Summary

This clinical trial update covers a Phase 1 study of the bispecific antibody 10E8.4/iMab and the VRC07-523LS monoclonal antibody in HIV-1-infected adults, which…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 10E8.4/iMab Bispecific Antibody
• VRC07-523LS Monoclonal Antibody

Snippet

Sponsor: David Ho | Conditions: HIV-1-infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING